Society

Go to archive

To date, the country has confirmed 145 cases of coronavirus infection including 75 cases in the city of Nur-Sultan, 50 cases in Almaty, 4 cases in the city of Karaganda, 2 cases in Shymkent, 1 case in Almaty region, 1 case in Aktobe region, 3 cases in Zhambyl region, 3 cases in Akmolinsk region, 3 cases in Atyrau region, 1 case in Pavlodar region, 1 case in Mangistau region and 1 case in North Kazakhstan region.

The President noted that Kazakhstanis being together will be able to win the battle against coronavirus. "The death of the 64-year-old woman indicates gravity of the coronavirus and utmost importance of observance of quarantine regulations. My sincere condolences to her family and relatives. It was decided to toughen quarantine measures in the Kazakh capital, Almaty and Shymkent," the Twitter post of the Kazakh President reads.

"The best-case scenario is that in summer, our European and American colleagues will be able to take control of this situation and prevent expansion of this epidemic wave. That would be very good," he said.

One new case of COVID-19 was registered in Kazakhstan's Shymkent. To date, the country has confirmed 80 cases of coronavirus infection including 41 cases in the city of Nur-Sultan, 31 cases in Almaty, 2 cases in the city of Karaganda, 1 case in Almaty region, 1 case in Aktobe region, 2 cases in Shymkent, 1 case in Zhambyl region and 1 case in North Kazakhstan region.

Prior to the appointment she headed the public healthcare policy department of the Healthcare Ministry.

44 laboratory-confirmed cases of coronavirus have been reported across the country for now, 19 - in Almaty and 25 - in Nur-Sultan.

Based on different scenarios for the impact of COVID-19 on global GDP growth, the ILO estimates indicate a rise in global unemployment of between 5.3 million ("low" scenario) and 24.7 million ("high" scenario) from a base level of 188 million in 2019.

One more coronavirus case was recorded in Nur-Sultan bringing the total number of infections to 33.

residents of Nur-Sultan and Almaty, who had previously left the city upon their return to the city;

Favipiravir, the influenza drug which was approved for clinical use in Japan in 2014, has shown no obvious adverse reactions in the clinical trial, said Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, at a press conference.